| For: | Zheng Y, Li H, Wang R, Jiang CS, Zhao YT. Multi-model applications and cutting-edge advancements of artificial intelligence in hepatology in the era of precision medicine. World J Gastroenterol 2025; 31(39): 111323 [PMID: 41180782 DOI: 10.3748/wjg.v31.i39.111323] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v31/i39/111323.htm |
| Number | Citing Articles |
| 1 |
Nasar Alwahaibi. Transforming Gastric Biopsy Diagnostics: Integrating Omics Technologies and Artificial Intelligence. Biomedicines 2026; 14(2) doi: 10.3390/biomedicines14020407
|
| 2 |
Xianting Liang, Junning He, Qiuting Wu, Lixiang Fu, Yongfang Liu. Gut microbiome in alcohol-associated liver disease: interactions and therapeutic strategies. Frontiers in Pharmacology 2026; 17 doi: 10.3389/fphar.2026.1770833
|
| 3 |
Mario Romeo, Claudio Basile, Andrea Imperatore, Giambattista Mozzi, Fiammetta Di Nardo, Carmine Napolitano, Paolo Vaia, Luigi Di Puorto, Mattia Indipendente, Marcello Dallio, Alessandro Federico. Peroxisome Proliferator-Activated Receptor (PPAR) Agonists in Chronic Liver Diseases: Translating Mechanistic Insights into Clinical Practice and Future Perspectives. Cells 2026; 15(14) doi: 10.3390/cells15141292
|
| 4 |
Yi Dang, Wenjing Li, Zhao Liu, Junqiang Lei. Research Progress on the Application of Radiomics and Deep Learning in Liver Fibrosis. Journal of Imaging 2026; 12(2) doi: 10.3390/jimaging12020082
|
| 5 |
Xiaoyan Wang, Runzhu Wang, Haotian Zhang, Yu Shi. Application of Artificial Intelligence Technology in the Comprehensive Management of Chronic Liver Disease: A Narrative Review on Technological Advances and Clinical Prospects. Infectious Microbes and Diseases 2026; 8(3) doi: 10.1097/IM9.0000000000000217
|